Supplementary Material for: Dynamic profiling of the immune tumor microenvironment in locally advanced gastric cancer treated with perioperative chemotherapy Article Swipe
YOU?
·
· 2023
· Open Access
·
· DOI: https://doi.org/10.6084/m9.figshare.23500872
Introduction: In locally advanced gastric cancer (GC), FLOT represents the standard perioperative regimen and combination with immunotherapy is under investigation. However, the role of immune tumor microenvironment (TME) is poorly recognized in this setting. We aimed to study TME characteristics and dynamics during FLOT. Methods: Paired biopsy (PRE) and surgical (POST) samples of 25 patients treated with FLOT were prospectively analyzed. After collection of clinic-pathological data, NanoString analyses were performed. The primary objective of the study was to assess the changes induced by chemotherapy in POST compared to PRE samples. Results: The unsupervised hierarchical method analysis clearly distinguished PRE and POST samples, even though some cases showed high immune gene expression at baseline. When POST samples were compared with PRE, a differential expression in hyper-expressed gene sets related to cytotoxicity, T-cell functions, complement system, tumor necrosis factor-superfamily, cell cycle and regulation was recognized. Downstaging of the primary tumor (T-regression, measured by pathologic compared to clinical T stage) was the covariate most frequently associated with these changes. Using the immune cell profiling, cases with T-regression reported a significant increase of T, CD8+ T and B-cells and a decrease in mast cells, while non-responders demonstrated an increase of T, B, cytotoxic and mast cells. Conclusion: Our analysis shows that FLOT significantly influences immune TME of GC. While relevant modifications preferentially occur in tumors showing primary tumor regression, response to treatment seems to be associated with a specific immune profile.
Related Topics
- Type
- dataset
- Language
- en
- Landing Page
- https://doi.org/10.6084/m9.figshare.23500872
- OA Status
- gold
- Related Works
- 10
- OpenAlex ID
- https://openalex.org/W4394367722
Raw OpenAlex JSON
- OpenAlex ID
-
https://openalex.org/W4394367722Canonical identifier for this work in OpenAlex
- DOI
-
https://doi.org/10.6084/m9.figshare.23500872Digital Object Identifier
- Title
-
Supplementary Material for: Dynamic profiling of the immune tumor microenvironment in locally advanced gastric cancer treated with perioperative chemotherapyWork title
- Type
-
datasetOpenAlex work type
- Language
-
enPrimary language
- Publication year
-
2023Year of publication
- Publication date
-
2023-01-01Full publication date if available
- Authors
-
Irene Pecora, Clara Ugolini, Riccardo Giannini, Mirella Giordano, Caterina Vivaldi, Monica Lencioni, S. Santi, Valentina Massa, Giovanni Pallabazzer, Silvia Catanese, Francesca Salani, Belluomini M.A., Enrico Vasile, Chiara Cremolini, Gabriella Fontanini, Gianluca Masi, Lorenzo FornaroList of authors in order
- Landing page
-
https://doi.org/10.6084/m9.figshare.23500872Publisher landing page
- Open access
-
YesWhether a free full text is available
- OA status
-
goldOpen access status per OpenAlex
- OA URL
-
https://doi.org/10.6084/m9.figshare.23500872Direct OA link when available
- Concepts
-
Profiling (computer programming), Tumor microenvironment, Medicine, Chemotherapy, Perioperative, Immune system, Cancer, Oncology, Cancer research, Internal medicine, Immunology, Computer science, Surgery, Operating systemTop concepts (fields/topics) attached by OpenAlex
- Cited by
-
0Total citation count in OpenAlex
- Related works (count)
-
10Other works algorithmically related by OpenAlex
Full payload
| id | https://openalex.org/W4394367722 |
|---|---|
| doi | https://doi.org/10.6084/m9.figshare.23500872 |
| ids.doi | https://doi.org/10.6084/m9.figshare.23500872 |
| ids.openalex | https://openalex.org/W4394367722 |
| fwci | |
| type | dataset |
| title | Supplementary Material for: Dynamic profiling of the immune tumor microenvironment in locally advanced gastric cancer treated with perioperative chemotherapy |
| biblio.issue | |
| biblio.volume | |
| biblio.last_page | |
| biblio.first_page | |
| topics[0].id | https://openalex.org/T11313 |
| topics[0].field.id | https://openalex.org/fields/24 |
| topics[0].field.display_name | Immunology and Microbiology |
| topics[0].score | 0.993399977684021 |
| topics[0].domain.id | https://openalex.org/domains/1 |
| topics[0].domain.display_name | Life Sciences |
| topics[0].subfield.id | https://openalex.org/subfields/2403 |
| topics[0].subfield.display_name | Immunology |
| topics[0].display_name | Immune cells in cancer |
| topics[1].id | https://openalex.org/T10158 |
| topics[1].field.id | https://openalex.org/fields/27 |
| topics[1].field.display_name | Medicine |
| topics[1].score | 0.9894999861717224 |
| topics[1].domain.id | https://openalex.org/domains/4 |
| topics[1].domain.display_name | Health Sciences |
| topics[1].subfield.id | https://openalex.org/subfields/2730 |
| topics[1].subfield.display_name | Oncology |
| topics[1].display_name | Cancer Immunotherapy and Biomarkers |
| topics[2].id | https://openalex.org/T10336 |
| topics[2].field.id | https://openalex.org/fields/27 |
| topics[2].field.display_name | Medicine |
| topics[2].score | 0.9894999861717224 |
| topics[2].domain.id | https://openalex.org/domains/4 |
| topics[2].domain.display_name | Health Sciences |
| topics[2].subfield.id | https://openalex.org/subfields/2730 |
| topics[2].subfield.display_name | Oncology |
| topics[2].display_name | Cancer Cells and Metastasis |
| is_xpac | False |
| apc_list | |
| apc_paid | |
| concepts[0].id | https://openalex.org/C187191949 |
| concepts[0].level | 2 |
| concepts[0].score | 0.7463186979293823 |
| concepts[0].wikidata | https://www.wikidata.org/wiki/Q1138496 |
| concepts[0].display_name | Profiling (computer programming) |
| concepts[1].id | https://openalex.org/C2776107976 |
| concepts[1].level | 3 |
| concepts[1].score | 0.5638928413391113 |
| concepts[1].wikidata | https://www.wikidata.org/wiki/Q1786433 |
| concepts[1].display_name | Tumor microenvironment |
| concepts[2].id | https://openalex.org/C71924100 |
| concepts[2].level | 0 |
| concepts[2].score | 0.5528197884559631 |
| concepts[2].wikidata | https://www.wikidata.org/wiki/Q11190 |
| concepts[2].display_name | Medicine |
| concepts[3].id | https://openalex.org/C2776694085 |
| concepts[3].level | 2 |
| concepts[3].score | 0.5462822318077087 |
| concepts[3].wikidata | https://www.wikidata.org/wiki/Q974135 |
| concepts[3].display_name | Chemotherapy |
| concepts[4].id | https://openalex.org/C31174226 |
| concepts[4].level | 2 |
| concepts[4].score | 0.5003135204315186 |
| concepts[4].wikidata | https://www.wikidata.org/wiki/Q64855140 |
| concepts[4].display_name | Perioperative |
| concepts[5].id | https://openalex.org/C8891405 |
| concepts[5].level | 2 |
| concepts[5].score | 0.49642664194107056 |
| concepts[5].wikidata | https://www.wikidata.org/wiki/Q1059 |
| concepts[5].display_name | Immune system |
| concepts[6].id | https://openalex.org/C121608353 |
| concepts[6].level | 2 |
| concepts[6].score | 0.47822660207748413 |
| concepts[6].wikidata | https://www.wikidata.org/wiki/Q12078 |
| concepts[6].display_name | Cancer |
| concepts[7].id | https://openalex.org/C143998085 |
| concepts[7].level | 1 |
| concepts[7].score | 0.4503251612186432 |
| concepts[7].wikidata | https://www.wikidata.org/wiki/Q162555 |
| concepts[7].display_name | Oncology |
| concepts[8].id | https://openalex.org/C502942594 |
| concepts[8].level | 1 |
| concepts[8].score | 0.36618393659591675 |
| concepts[8].wikidata | https://www.wikidata.org/wiki/Q3421914 |
| concepts[8].display_name | Cancer research |
| concepts[9].id | https://openalex.org/C126322002 |
| concepts[9].level | 1 |
| concepts[9].score | 0.33244818449020386 |
| concepts[9].wikidata | https://www.wikidata.org/wiki/Q11180 |
| concepts[9].display_name | Internal medicine |
| concepts[10].id | https://openalex.org/C203014093 |
| concepts[10].level | 1 |
| concepts[10].score | 0.2628413140773773 |
| concepts[10].wikidata | https://www.wikidata.org/wiki/Q101929 |
| concepts[10].display_name | Immunology |
| concepts[11].id | https://openalex.org/C41008148 |
| concepts[11].level | 0 |
| concepts[11].score | 0.15530827641487122 |
| concepts[11].wikidata | https://www.wikidata.org/wiki/Q21198 |
| concepts[11].display_name | Computer science |
| concepts[12].id | https://openalex.org/C141071460 |
| concepts[12].level | 1 |
| concepts[12].score | 0.14639082551002502 |
| concepts[12].wikidata | https://www.wikidata.org/wiki/Q40821 |
| concepts[12].display_name | Surgery |
| concepts[13].id | https://openalex.org/C111919701 |
| concepts[13].level | 1 |
| concepts[13].score | 0.0 |
| concepts[13].wikidata | https://www.wikidata.org/wiki/Q9135 |
| concepts[13].display_name | Operating system |
| keywords[0].id | https://openalex.org/keywords/profiling |
| keywords[0].score | 0.7463186979293823 |
| keywords[0].display_name | Profiling (computer programming) |
| keywords[1].id | https://openalex.org/keywords/tumor-microenvironment |
| keywords[1].score | 0.5638928413391113 |
| keywords[1].display_name | Tumor microenvironment |
| keywords[2].id | https://openalex.org/keywords/medicine |
| keywords[2].score | 0.5528197884559631 |
| keywords[2].display_name | Medicine |
| keywords[3].id | https://openalex.org/keywords/chemotherapy |
| keywords[3].score | 0.5462822318077087 |
| keywords[3].display_name | Chemotherapy |
| keywords[4].id | https://openalex.org/keywords/perioperative |
| keywords[4].score | 0.5003135204315186 |
| keywords[4].display_name | Perioperative |
| keywords[5].id | https://openalex.org/keywords/immune-system |
| keywords[5].score | 0.49642664194107056 |
| keywords[5].display_name | Immune system |
| keywords[6].id | https://openalex.org/keywords/cancer |
| keywords[6].score | 0.47822660207748413 |
| keywords[6].display_name | Cancer |
| keywords[7].id | https://openalex.org/keywords/oncology |
| keywords[7].score | 0.4503251612186432 |
| keywords[7].display_name | Oncology |
| keywords[8].id | https://openalex.org/keywords/cancer-research |
| keywords[8].score | 0.36618393659591675 |
| keywords[8].display_name | Cancer research |
| keywords[9].id | https://openalex.org/keywords/internal-medicine |
| keywords[9].score | 0.33244818449020386 |
| keywords[9].display_name | Internal medicine |
| keywords[10].id | https://openalex.org/keywords/immunology |
| keywords[10].score | 0.2628413140773773 |
| keywords[10].display_name | Immunology |
| keywords[11].id | https://openalex.org/keywords/computer-science |
| keywords[11].score | 0.15530827641487122 |
| keywords[11].display_name | Computer science |
| keywords[12].id | https://openalex.org/keywords/surgery |
| keywords[12].score | 0.14639082551002502 |
| keywords[12].display_name | Surgery |
| language | en |
| locations[0].id | doi:10.6084/m9.figshare.23500872 |
| locations[0].is_oa | True |
| locations[0].source | |
| locations[0].license | cc-by |
| locations[0].pdf_url | |
| locations[0].version | |
| locations[0].raw_type | dataset |
| locations[0].license_id | https://openalex.org/licenses/cc-by |
| locations[0].is_accepted | False |
| locations[0].is_published | |
| locations[0].raw_source_name | |
| locations[0].landing_page_url | https://doi.org/10.6084/m9.figshare.23500872 |
| indexed_in | datacite |
| authorships[0].author.id | https://openalex.org/A5056137515 |
| authorships[0].author.orcid | https://orcid.org/0000-0003-2644-2993 |
| authorships[0].author.display_name | Irene Pecora |
| authorships[0].author_position | first |
| authorships[0].raw_author_name | Pecora I. |
| authorships[0].is_corresponding | False |
| authorships[1].author.id | https://openalex.org/A5008698979 |
| authorships[1].author.orcid | https://orcid.org/0000-0002-3489-8280 |
| authorships[1].author.display_name | Clara Ugolini |
| authorships[1].author_position | middle |
| authorships[1].raw_author_name | Ugolini C. |
| authorships[1].is_corresponding | False |
| authorships[2].author.id | https://openalex.org/A5025879797 |
| authorships[2].author.orcid | https://orcid.org/0000-0001-9740-0219 |
| authorships[2].author.display_name | Riccardo Giannini |
| authorships[2].author_position | middle |
| authorships[2].raw_author_name | Giannini R. |
| authorships[2].is_corresponding | False |
| authorships[3].author.id | https://openalex.org/A5017086518 |
| authorships[3].author.orcid | https://orcid.org/0009-0003-0445-4501 |
| authorships[3].author.display_name | Mirella Giordano |
| authorships[3].author_position | middle |
| authorships[3].raw_author_name | Giordano M. |
| authorships[3].is_corresponding | False |
| authorships[4].author.id | https://openalex.org/A5037539040 |
| authorships[4].author.orcid | https://orcid.org/0000-0001-9307-2326 |
| authorships[4].author.display_name | Caterina Vivaldi |
| authorships[4].author_position | middle |
| authorships[4].raw_author_name | Vivaldi C. |
| authorships[4].is_corresponding | False |
| authorships[5].author.id | https://openalex.org/A5009272132 |
| authorships[5].author.orcid | |
| authorships[5].author.display_name | Monica Lencioni |
| authorships[5].author_position | middle |
| authorships[5].raw_author_name | Lencioni M. |
| authorships[5].is_corresponding | False |
| authorships[6].author.id | https://openalex.org/A5111311737 |
| authorships[6].author.orcid | |
| authorships[6].author.display_name | S. Santi |
| authorships[6].author_position | middle |
| authorships[6].raw_author_name | Santi S. |
| authorships[6].is_corresponding | False |
| authorships[7].author.id | https://openalex.org/A5111168645 |
| authorships[7].author.orcid | |
| authorships[7].author.display_name | Valentina Massa |
| authorships[7].author_position | middle |
| authorships[7].raw_author_name | Massa V. |
| authorships[7].is_corresponding | False |
| authorships[8].author.id | https://openalex.org/A5061708924 |
| authorships[8].author.orcid | https://orcid.org/0000-0003-2495-7635 |
| authorships[8].author.display_name | Giovanni Pallabazzer |
| authorships[8].author_position | middle |
| authorships[8].raw_author_name | Pallabazzer G. |
| authorships[8].is_corresponding | False |
| authorships[9].author.id | https://openalex.org/A5026345672 |
| authorships[9].author.orcid | https://orcid.org/0000-0002-4937-9942 |
| authorships[9].author.display_name | Silvia Catanese |
| authorships[9].author_position | middle |
| authorships[9].raw_author_name | Catanese S. |
| authorships[9].is_corresponding | False |
| authorships[10].author.id | https://openalex.org/A5019141029 |
| authorships[10].author.orcid | https://orcid.org/0000-0001-7749-8634 |
| authorships[10].author.display_name | Francesca Salani |
| authorships[10].author_position | middle |
| authorships[10].raw_author_name | Salani F. |
| authorships[10].is_corresponding | False |
| authorships[11].author.id | https://openalex.org/A5095063326 |
| authorships[11].author.orcid | |
| authorships[11].author.display_name | Belluomini M.A. |
| authorships[11].author_position | middle |
| authorships[11].raw_author_name | Belluomini M.A. |
| authorships[11].is_corresponding | False |
| authorships[12].author.id | https://openalex.org/A5082066847 |
| authorships[12].author.orcid | https://orcid.org/0000-0002-8482-6963 |
| authorships[12].author.display_name | Enrico Vasile |
| authorships[12].author_position | middle |
| authorships[12].raw_author_name | Vasile E. |
| authorships[12].is_corresponding | False |
| authorships[13].author.id | https://openalex.org/A5081985776 |
| authorships[13].author.orcid | https://orcid.org/0000-0002-0520-4841 |
| authorships[13].author.display_name | Chiara Cremolini |
| authorships[13].author_position | middle |
| authorships[13].raw_author_name | Cremolini C. |
| authorships[13].is_corresponding | False |
| authorships[14].author.id | https://openalex.org/A5017474339 |
| authorships[14].author.orcid | https://orcid.org/0000-0003-1957-2052 |
| authorships[14].author.display_name | Gabriella Fontanini |
| authorships[14].author_position | middle |
| authorships[14].raw_author_name | Fontanini G. |
| authorships[14].is_corresponding | False |
| authorships[15].author.id | https://openalex.org/A5058514609 |
| authorships[15].author.orcid | https://orcid.org/0000-0001-8329-8989 |
| authorships[15].author.display_name | Gianluca Masi |
| authorships[15].author_position | middle |
| authorships[15].raw_author_name | Masi G. |
| authorships[15].is_corresponding | False |
| authorships[16].author.id | https://openalex.org/A5036615333 |
| authorships[16].author.orcid | https://orcid.org/0000-0002-0187-5904 |
| authorships[16].author.display_name | Lorenzo Fornaro |
| authorships[16].author_position | last |
| authorships[16].raw_author_name | Fornaro L. |
| authorships[16].is_corresponding | False |
| has_content.pdf | False |
| has_content.grobid_xml | False |
| is_paratext | False |
| open_access.is_oa | True |
| open_access.oa_url | https://doi.org/10.6084/m9.figshare.23500872 |
| open_access.oa_status | gold |
| open_access.any_repository_has_fulltext | False |
| created_date | 2025-10-10T00:00:00 |
| display_name | Supplementary Material for: Dynamic profiling of the immune tumor microenvironment in locally advanced gastric cancer treated with perioperative chemotherapy |
| has_fulltext | False |
| is_retracted | False |
| updated_date | 2025-11-06T06:51:31.235846 |
| primary_topic.id | https://openalex.org/T11313 |
| primary_topic.field.id | https://openalex.org/fields/24 |
| primary_topic.field.display_name | Immunology and Microbiology |
| primary_topic.score | 0.993399977684021 |
| primary_topic.domain.id | https://openalex.org/domains/1 |
| primary_topic.domain.display_name | Life Sciences |
| primary_topic.subfield.id | https://openalex.org/subfields/2403 |
| primary_topic.subfield.display_name | Immunology |
| primary_topic.display_name | Immune cells in cancer |
| related_works | https://openalex.org/W200942561, https://openalex.org/W2161444195, https://openalex.org/W4285792917, https://openalex.org/W2954763902, https://openalex.org/W2589019771, https://openalex.org/W1969612914, https://openalex.org/W2985540061, https://openalex.org/W1989843070, https://openalex.org/W1589001095, https://openalex.org/W3031001356 |
| cited_by_count | 0 |
| locations_count | 1 |
| best_oa_location.id | doi:10.6084/m9.figshare.23500872 |
| best_oa_location.is_oa | True |
| best_oa_location.source | |
| best_oa_location.license | cc-by |
| best_oa_location.pdf_url | |
| best_oa_location.version | |
| best_oa_location.raw_type | dataset |
| best_oa_location.license_id | https://openalex.org/licenses/cc-by |
| best_oa_location.is_accepted | False |
| best_oa_location.is_published | False |
| best_oa_location.raw_source_name | |
| best_oa_location.landing_page_url | https://doi.org/10.6084/m9.figshare.23500872 |
| primary_location.id | doi:10.6084/m9.figshare.23500872 |
| primary_location.is_oa | True |
| primary_location.source | |
| primary_location.license | cc-by |
| primary_location.pdf_url | |
| primary_location.version | |
| primary_location.raw_type | dataset |
| primary_location.license_id | https://openalex.org/licenses/cc-by |
| primary_location.is_accepted | False |
| primary_location.is_published | False |
| primary_location.raw_source_name | |
| primary_location.landing_page_url | https://doi.org/10.6084/m9.figshare.23500872 |
| publication_date | 2023-01-01 |
| publication_year | 2023 |
| referenced_works_count | 0 |
| abstract_inverted_index.T | 155, 181 |
| abstract_inverted_index.a | 120, 175, 185, 233 |
| abstract_inverted_index.25 | 53 |
| abstract_inverted_index.B, | 197 |
| abstract_inverted_index.In | 1 |
| abstract_inverted_index.T, | 179, 196 |
| abstract_inverted_index.We | 34 |
| abstract_inverted_index.an | 193 |
| abstract_inverted_index.at | 111 |
| abstract_inverted_index.be | 230 |
| abstract_inverted_index.by | 82, 150 |
| abstract_inverted_index.in | 31, 84, 123, 187, 219 |
| abstract_inverted_index.is | 17, 28 |
| abstract_inverted_index.of | 23, 52, 63, 73, 144, 178, 195, 212 |
| abstract_inverted_index.to | 36, 77, 87, 128, 153, 226, 229 |
| abstract_inverted_index.GC. | 213 |
| abstract_inverted_index.Our | 203 |
| abstract_inverted_index.PRE | 88, 98 |
| abstract_inverted_index.TME | 38, 211 |
| abstract_inverted_index.The | 70, 91 |
| abstract_inverted_index.and | 13, 40, 48, 99, 139, 182, 184, 199 |
| abstract_inverted_index.the | 9, 21, 74, 79, 145, 158, 167 |
| abstract_inverted_index.was | 76, 141, 157 |
| abstract_inverted_index.CD8+ | 180 |
| abstract_inverted_index.FLOT | 7, 57, 207 |
| abstract_inverted_index.POST | 85, 100, 114 |
| abstract_inverted_index.PRE, | 119 |
| abstract_inverted_index.When | 113 |
| abstract_inverted_index.cell | 137, 169 |
| abstract_inverted_index.even | 102 |
| abstract_inverted_index.gene | 109, 125 |
| abstract_inverted_index.high | 107 |
| abstract_inverted_index.mast | 188, 200 |
| abstract_inverted_index.most | 160 |
| abstract_inverted_index.role | 22 |
| abstract_inverted_index.sets | 126 |
| abstract_inverted_index.some | 104 |
| abstract_inverted_index.that | 206 |
| abstract_inverted_index.this | 32 |
| abstract_inverted_index.were | 58, 68, 116 |
| abstract_inverted_index.with | 15, 56, 118, 163, 172, 232 |
| abstract_inverted_index.(GC), | 6 |
| abstract_inverted_index.(PRE) | 47 |
| abstract_inverted_index.(TME) | 27 |
| abstract_inverted_index.After | 61 |
| abstract_inverted_index.FLOT. | 43 |
| abstract_inverted_index.Using | 166 |
| abstract_inverted_index.While | 214 |
| abstract_inverted_index.aimed | 35 |
| abstract_inverted_index.cases | 105, 171 |
| abstract_inverted_index.cycle | 138 |
| abstract_inverted_index.data, | 65 |
| abstract_inverted_index.occur | 218 |
| abstract_inverted_index.seems | 228 |
| abstract_inverted_index.shows | 205 |
| abstract_inverted_index.study | 37, 75 |
| abstract_inverted_index.these | 164 |
| abstract_inverted_index.tumor | 25, 134, 147, 223 |
| abstract_inverted_index.under | 18 |
| abstract_inverted_index.while | 190 |
| abstract_inverted_index.(POST) | 50 |
| abstract_inverted_index.Paired | 45 |
| abstract_inverted_index.T-cell | 130 |
| abstract_inverted_index.assess | 78 |
| abstract_inverted_index.biopsy | 46 |
| abstract_inverted_index.cancer | 5 |
| abstract_inverted_index.cells, | 189 |
| abstract_inverted_index.cells. | 201 |
| abstract_inverted_index.during | 42 |
| abstract_inverted_index.immune | 24, 108, 168, 210, 235 |
| abstract_inverted_index.method | 94 |
| abstract_inverted_index.poorly | 29 |
| abstract_inverted_index.showed | 106 |
| abstract_inverted_index.stage) | 156 |
| abstract_inverted_index.though | 103 |
| abstract_inverted_index.tumors | 220 |
| abstract_inverted_index.B-cells | 183 |
| abstract_inverted_index.changes | 80 |
| abstract_inverted_index.clearly | 96 |
| abstract_inverted_index.gastric | 4 |
| abstract_inverted_index.induced | 81 |
| abstract_inverted_index.locally | 2 |
| abstract_inverted_index.primary | 71, 146, 222 |
| abstract_inverted_index.regimen | 12 |
| abstract_inverted_index.related | 127 |
| abstract_inverted_index.samples | 51, 115 |
| abstract_inverted_index.showing | 221 |
| abstract_inverted_index.system, | 133 |
| abstract_inverted_index.treated | 55 |
| abstract_inverted_index.However, | 20 |
| abstract_inverted_index.Methods: | 44 |
| abstract_inverted_index.Results: | 90 |
| abstract_inverted_index.advanced | 3 |
| abstract_inverted_index.analyses | 67 |
| abstract_inverted_index.analysis | 95, 204 |
| abstract_inverted_index.changes. | 165 |
| abstract_inverted_index.clinical | 154 |
| abstract_inverted_index.compared | 86, 117, 152 |
| abstract_inverted_index.decrease | 186 |
| abstract_inverted_index.dynamics | 41 |
| abstract_inverted_index.increase | 177, 194 |
| abstract_inverted_index.measured | 149 |
| abstract_inverted_index.necrosis | 135 |
| abstract_inverted_index.patients | 54 |
| abstract_inverted_index.profile. | 236 |
| abstract_inverted_index.relevant | 215 |
| abstract_inverted_index.reported | 174 |
| abstract_inverted_index.response | 225 |
| abstract_inverted_index.samples, | 101 |
| abstract_inverted_index.samples. | 89 |
| abstract_inverted_index.setting. | 33 |
| abstract_inverted_index.specific | 234 |
| abstract_inverted_index.standard | 10 |
| abstract_inverted_index.surgical | 49 |
| abstract_inverted_index.analyzed. | 60 |
| abstract_inverted_index.baseline. | 112 |
| abstract_inverted_index.covariate | 159 |
| abstract_inverted_index.cytotoxic | 198 |
| abstract_inverted_index.objective | 72 |
| abstract_inverted_index.treatment | 227 |
| abstract_inverted_index.NanoString | 66 |
| abstract_inverted_index.associated | 162, 231 |
| abstract_inverted_index.collection | 62 |
| abstract_inverted_index.complement | 132 |
| abstract_inverted_index.expression | 110, 122 |
| abstract_inverted_index.frequently | 161 |
| abstract_inverted_index.functions, | 131 |
| abstract_inverted_index.influences | 209 |
| abstract_inverted_index.pathologic | 151 |
| abstract_inverted_index.performed. | 69 |
| abstract_inverted_index.profiling, | 170 |
| abstract_inverted_index.recognized | 30 |
| abstract_inverted_index.regulation | 140 |
| abstract_inverted_index.represents | 8 |
| abstract_inverted_index.Conclusion: | 202 |
| abstract_inverted_index.Downstaging | 143 |
| abstract_inverted_index.combination | 14 |
| abstract_inverted_index.recognized. | 142 |
| abstract_inverted_index.regression, | 224 |
| abstract_inverted_index.significant | 176 |
| abstract_inverted_index.T-regression | 173 |
| abstract_inverted_index.chemotherapy | 83 |
| abstract_inverted_index.demonstrated | 192 |
| abstract_inverted_index.differential | 121 |
| abstract_inverted_index.hierarchical | 93 |
| abstract_inverted_index.unsupervised | 92 |
| abstract_inverted_index.Introduction: | 0 |
| abstract_inverted_index.cytotoxicity, | 129 |
| abstract_inverted_index.distinguished | 97 |
| abstract_inverted_index.immunotherapy | 16 |
| abstract_inverted_index.modifications | 216 |
| abstract_inverted_index.perioperative | 11 |
| abstract_inverted_index.prospectively | 59 |
| abstract_inverted_index.significantly | 208 |
| abstract_inverted_index.(T-regression, | 148 |
| abstract_inverted_index.investigation. | 19 |
| abstract_inverted_index.non-responders | 191 |
| abstract_inverted_index.preferentially | 217 |
| abstract_inverted_index.characteristics | 39 |
| abstract_inverted_index.hyper-expressed | 124 |
| abstract_inverted_index.microenvironment | 26 |
| abstract_inverted_index.clinic-pathological | 64 |
| abstract_inverted_index.factor-superfamily, | 136 |
| cited_by_percentile_year | |
| countries_distinct_count | 0 |
| institutions_distinct_count | 17 |
| citation_normalized_percentile |